0512-80988088
当前位置:首页 >产品中心 >定量POCT产品 >心脏疾病诊断 心脏疾病诊断

MYO Quantitative Diagnostic Kit

Time-Resolved Fluorescent Immunochromatographic Assay

【Introduction】

With time-resolved fluorescence immuno-chromatographic methods as the core technology and based on double-antibody sandwich assay, myoblobin (MYO) quantitative detection kit is applicable for quantitatively determination of MYO levels in human blood in vitro.

【Clinical significance】

1. As myocardial infarction (AMI) early detection indicators, highly sensitive;
2. Peaked 1-3h after the onset;
3. Diagnose reinfarction or infarct extension;
4. Determine myocardial reperfusion.

【Advantages】

1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography, get result within 30s
2. Quantitative: quantitative detection of myocardial infarction markers MYO
3. Accurate: consistent with results by imported chemiluminescence reagent (r> 0.975)
4. Highly sensitive: lower detection limit <40pg / mL
5. Simple: simple operation, suitable for bedside detection, section for outpatients and emergency call
6. Widely applicable: can be used for outpatient laboratory, emergency laboratory, medical center, cardiology, ICU, and etc.




返回顶部

更早
2016年02月

手持仪器PocRoc 2S获得注册证

2015年10月

再获5个生化项目注册证,光景生化项目达到10项!

2015年07月

获得CE认证

2014年04月

获得4个即时诊断(POCT)产品注册证书

2014年03月

获得5个纳米微球增强生化产品注册证书

2014年02月

获得时间分辨荧光免疫分析仪产品注册证书

2014年01月

何爱民博士入选“国家千人计划创业人才”